CompaniesSMWB
S1Overview
SMWB
Similarweb
TechnologySaaSWeb AnalyticsWatchlist
$4.38+1.9%
Market Cap
$360M
company IR
P/E (TTM)
—
via financials
Rev Growth YoY
13.0%
+13%SEC filing
Gross Margin
78.0%
SEC filing
FCF Yield
—
calculated
Upside to FV
—
vs fair value
Conviction
3/5Digital-intelligence SaaS under 40-agent forensic review — fair but not yet cheap; a research-stage watchlist name.
Research Depth
ScreeningDeep DiveFull Model
Updated 19d ago
S2Thesis
Similarweb sells web and app traffic intelligence as a subscription. A 40-agent forensic review characterized it as a fair-but-not-cheap SaaS turnaround: ~78% gross margins and a defensible data panel, but still operating at a loss with an unproven path to GAAP profitability. The research conclusion is that the valuation is not yet compelling at current levels.
Bull Case
Margins~78% gross margin; recurring subscription revenue.
Data MoatProprietary traffic panel is hard to replicate at scale.
Bear Case
ProfitabilityStill operating at a loss; path to GAAP profit unproven.
ValuationNot yet cheap enough relative to the operating-loss profile.
S3Key Metrics
Market Cap
$360M
company IR
Enterprise Value
$320M
calculated
Revenue (TTM)
$280M
SEC filing
P/E (TTM)
—
via financials
Forward P/E
[awaiting: consensus]
consensus
P/S (TTM)
1.3×
via financials
P/B
3.0×
via financials
EV/EBITDA
—
calculated
PEG
—
calculated
Revenue Growth
13.0%
SEC filing
Gross Margin
78.0%
SEC filing
Operating Margin
-5.0%
SEC filing
Net Margin
-8.0%
SEC filing
Free Cash Flow
[awaiting: filing]
SEC filing
FCF Yield
—
calculated
Debt / Equity
0.1×
SEC filing
Current Ratio
1.3×
SEC filing
Short Interest
[awaiting: exchange]
exchange
Institutional Own.
[awaiting: 13F]
13F
Insider Own.
[awaiting: proxy]
proxy
Shares Out.
82.0M
SEC filing
Float
60.0M
exchange
S4Valuation
Price vs Fair Value
Valuation pending
Scenario fair-value range awaiting model.
DCF Summary
DCF awaiting Phase 2+
Discounted cash-flow model is built once research reaches Deep Dive.
Historical Multiples
Multiple history pending
This section is being deepened.
Peer Comparison
Peer set pending
Comparable companies awaiting selection.
S5Financials
Income statement pending
Awaiting SEC filing backfill.
Balance sheet pending
Awaiting SEC filing backfill.
Cash flow pending
Awaiting SEC filing backfill.
Awaiting filing backfill.
S6Catalysts
Q3 '26
Earnings
Q2 2026 earnings
Watch net revenue retention and FCF.
S7Risks
| Risk | Category | Severity | Probability | Impact on Thesis |
|---|---|---|---|---|
| Unproven path to profitability | Execution | Medium | Medium | Operating losses; quality is fine but valuation is not yet compelling. |
S8Technical Snapshot
52-Week Range
$3.00$4.38$8.50
RSI (14)
44
neutral
50-Day MA
$4.60
-4.8%below
200-Day MA
$5.50
-20.4%below
Avg Vol (30d)
0.9M
-10%vs average
Support Levels
$4.00$3.00
Resistance Levels
$5.00$6.00
Price path reconstructed from the 52-week range, current price, and 50/200-day moving averages — connect a live market-data feed for production.
S9Ownership & Insider Activity
Top Institutional Holders via 13F filings
13F holdings pending
Institutional holder detail awaiting filing.
Insider Activity
Insider transactions pending
This section is being deepened.
S10Peer Comparison
Peer set pending
Comparable companies awaiting selection.
S11Research Notes
2026-05-28Internal
40-agent forensic complete
Quality is fine but the valuation is not compelling at current levels. Classified as a research-stage watchlist name pending a cheaper entry or improving profitability.